Enrichment of genes involved in mTOR signaling and OXPHOS pathways in platelets from MPN patients was also observed in proteomics analyses (Figure 3, C and D), consistent with our scRNA-seq data. The gene discussed is MTOR; the disease is myeloproliferative disorder.